Clinical Trial Update: Effect of Oral Decontamination Using Chlorhexidine or Potassium Permanganate in ICU Patients [Phase 4]

View source ↗

Summary

A Phase 4 trial assessing oral decontamination with chlorhexidine or potassium permanganate in ICU patients to prevent pneumonia; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aspiration Pneumonia
• Healthcare-associated Pneumonia
• Nosocomial Pneumonia
• Ventilator-associated Pneumonia

Drugs mentioned

• Chlorhexidine digluconate (Chlorhexidine digluconate)
• Potassium permanganate (potassium permanganate)

Snippet

Sponsor: King Edward Memorial Hospital | Conditions: Nosocomial Pneumonia, Healthcare-Associated Pneumonia | Phase 4 | Status: COMPLETED